Trk receptor tyrosine kinases: a bridge between cancer and neural development.

The proto-oncogene Trks encode the high-affinity receptor tyrosine kinases for neurotrophins of a nerve growth factor (NGF) family. The Trk signals spatiotemporally regulate neural development and maintenance of neural network. However, Trk was originally cloned as an oncogene fused with the tropomyosin gene in the extracellular domain. Accumulating evidence has demonstrated that the rearranged Trk oncogene is often observed in non-neuronal neoplasms such as colon and papillary thyroid cancers, while the signals through the receptors encoded by the proto-oncogene Trks regulate growth, differentiation and apoptosis of the tumors with neuronal origin such as neuroblastoma and medulloblastoma. The intracellular Trk signaling pathway is also different depending on the Trk family receptors, cell types and the grade of transformation. Furthermore, developmentally programmed cell death of neuron, which is largely regulated by neurotrophin signaling, is at least in part controlled by tumor suppressors p53 and p73 as well as their antagonist DeltaNp73. Thus, the Trks and their downstream signaling function in both ontogenesis and oncogenesis. In this short review, the dynamic role of the Trk family receptors signaling in neural development, neurogenic tumors and other cancers will be discussed.

[1]  S. Pomeroy,et al.  Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Barbacid,et al.  The trk family of tyrosine protein kinase receptors. , 1991, Biochimica et biophysica acta.

[3]  W. Snider,et al.  Functions of the neurotrophins during nervous system development: What the knockouts are teaching us , 1994, Cell.

[4]  B. Hempstead,et al.  TrkA Immunoglobulin-Like Ligand Binding Domains Inhibit Spontaneous Activation of the Receptor , 2000, Molecular and Cellular Biology.

[5]  A. Nakagawara Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. , 1998, Human cell.

[6]  A. Cantor,et al.  Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. , 1993, The New England journal of medicine.

[7]  T. Sladek,et al.  Mediation of Nerve Growth Factor-driven Cell Cycle Arrest in PC12 Cells by p53 , 2000, The Journal of Biological Chemistry.

[8]  U. Moll,et al.  Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Seki,et al.  Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFRα-1, and GFRα-2 , 1998 .

[10]  L. Klesse,et al.  Trks: Signal transduction and intracellular pathways , 1999, Microscopy research and technique.

[11]  A. Nakagawara,et al.  Expression of TrkC in favorable human neuroblastomas. , 1996, Oncogene.

[12]  C. Pozniak,et al.  P53 Is Essential for Developmental Neuron Death as Regulated by the TrkA and p75 Neurotrophin Receptors , 1998, The Journal of cell biology.

[13]  S. Ménard,et al.  Nerve Growth Factor Cooperates with p185 HER2 in Activating Growth of Human Breast Carcinoma Cells* , 2000, The Journal of Biological Chemistry.

[14]  D. Stram,et al.  Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. , 1993, Journal of the National Cancer Institute.

[15]  F. McCormick,et al.  Opposing Effects of Ras on p53 Transcriptional Activation of mdm2 and Induction of p19ARF , 2000, Cell.

[16]  M. Caligiuri,et al.  Identification and Characterization of an Activating TrkA Deletion Mutation in Acute Myeloid Leukemia , 2022 .

[17]  K. Matsumoto,et al.  Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. , 1995, Cancer research.

[18]  A. Iavarone,et al.  Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins , 2000, Nature.

[19]  G. Evan,et al.  Cell Cycle Phase-Specific Surface Expression of Nerve Growth Factor Receptors TrkA and p75NTR , 1998, The Journal of Neuroscience.

[20]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[21]  A. Nakagawara,et al.  Expression and function of TRK-B and BDNF in human neuroblastomas , 1994, Molecular and cellular biology.

[22]  R. Klein Role of neurotrophins in mouse neuronal development , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  C. Thiele,et al.  Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. , 1999, The American journal of pathology.

[24]  J. Trojanowski,et al.  Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells , 2000, Oncogene.

[25]  M. Barbacid,et al.  The trk proto-oncogene encodes a receptor for nerve growth factor , 1991, Cell.

[26]  M. Arima,et al.  Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. , 1992, Cancer research.

[27]  J. Trojanowski,et al.  A Novel Apoptotic Pathway Induced by Nerve Growth Factor-mediated TrkA Activation in Medulloblastoma* , 2000, The Journal of Biological Chemistry.

[28]  K. Tanaka,et al.  Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). , 1999, Blood.

[29]  R. Levi‐montalcini,et al.  The nerve growth factor 35 years later. , 1987, Science.

[30]  R. Birge,et al.  Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor , 2000, Journal of neuroscience research.

[31]  A. Nakagawara Topical Topic: The NGF story and neuroblastoma , 1998 .

[32]  G. Melino,et al.  Induction of Neuronal Differentiation by p73 in a Neuroblastoma Cell Line* , 2000, The Journal of Biological Chemistry.

[33]  S. Baylin,et al.  Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. May,et al.  Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis , 2000, Oncogene.

[35]  A. Ross,et al.  Gene transfer and molecular cloning of the human NGF receptor. , 1986, Science.

[36]  D. Kaplan,et al.  High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor , 1991, Nature.

[37]  F. McKeon,et al.  An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. , 2000, Science.

[38]  F. McKeon,et al.  p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent , 1999, Oncogene.